Hospital Practices and Research

Biological and Immunological Aspects of Emerging and Re-emerging Avian Influenza and Ebola Diseases

Document Type : Review Article

Authors

Nader Nezamdoost Shadbad 1
Shabnam Bahrami 2
Seyed Mohammad Razdar 3

1 Applied Virology Research Center, Baqiyatallah University of Medical Science, Tehran, Iran

2 Department of Molecular Cell Biology and Genetics, Bushehr Branch, Islamic Azad University, Bushehr, Iran

3 Department of International Relations and Political Science, Zanjan Branch, Islamic Azad University, Zanjan, Iran

https://doi.org/10.30491/hpr.2023.423609.1406
Abstract
The countries located in west Asia and other parts of Asia are positioned in important and strategic areas due to specific political and geopolitical conditions. These countries have faced various military and political threats, and it is crucial for them to strengthen their ability to foresee, prevent, and prepare for any biological threats. Meanwhile, with the progress made in science and technology, particularly in the field of biology, new biological threats and wars have surfaced. These threats and wars are self-replicating and can significantly expand the contaminated area, requiring advanced equipment and resources in the community in order to combat them effectively. The field of threat detection, cleanup, and contamination has been identified as an area of concern. Additionally, the hidden use of these factors in peacetime poses a potential danger, as does the possibility of deliberate casualties and damages, along with the incidence of intense fear and panic in the target population. Given the recent outbreak of the avian influenza virus in some countries, there is a concern that avian influenza virus outbreaks could be a precursor to a more widespread and severe biological attack, such as the Ebola virus, which presents with widespread biological and clinical symptoms.

Keywords

Avian Influenza
Ebola
Hemorrhagic Fever
Surface Water-Borne Viruses
  1. Janik E, Ceremuga M, Saluk-Bijak J, Bijak M. Biological toxins as the potential tools for bioterrorism. Int J Mol Sci. 2019;20(5):1181. doi:10.3390/ijms20051181
  2. Jansen HJ, Breeveld FJ, Stijnis C, Grobusch MP. Biological warfare, bioterrorism, and biocrime. Clin Microbiol Infect. 2014;20(6):488-96. doi:1111/1469-0691.12699
  3. Gaur K, Iyer K, Pola S, Gupta R, Gadipelli AK. The clostridiu m perfringens epsilon toxin as a bioterrorism weapon. J Microb Biochem Techno l S. 2014;8. doi:10.4172/1948-5948.S8-009
  4. Madad SS. Bioterrorism: an emerging global health threat. JBBS. 2014;5(1):129.
  5. Zalman A. The Social and Psychological Effects of Bioterrorism. Bioterrorism: Threats and Deterrents. IOS Press; 2010. pp. 1-11. doi:10.3233/978-1-60750-501-3-1
  6. Wagar E. Bioterrorism and the role of the clinical microbiology laboratory. Clin Microbiol Rev. 2016;29(1): 175-89. doi:10.1128/cmr.00033-15
  7. Khan SU, Gurley ES, Gerloff N, Rahman MZ, Simpson N, Rahman M, et al. Avian influenza surveillance in domestic waterfowl and environment of live bird markets in Bangladesh, 2007–2012. Sci Rep. 2018;8(1):9396. doi:10.1 038/s41598-018-27515-w
  8. Klimov A, Balish A, Veguilla V, Sun H, Schiffer J, Lu X, et al. Influenza virus titration, antigenic characterization, and serological methods for antibody detection. Influenza Virus: Methods and Protocols. 2012:25-51. doi:10.1007/978-1-61779-621-0_3
  9. Yu H, Wu JT, Cowling BJ, Liao Q, Fang VJ, Zhou S, et al. Effect of closure of live poultry markets on poultry-to-person transmission of avian influenza A H7N9 virus: an ecological study. Lancet. 2014;383(9916):541-8. doi:10.1016/S0140-67 36(13)61904-2
  10. Azziz-Baumgartner E, Alamgir AS, Rahman M, Homaira N, Sohel BM, Sharker MA, et al. Incidence of influenza-like illness and severe acute respiratory infection during three influenza seasons in Bangladesh, 2008-2010. Bull World Health Organ. 2012;90:12-9. doi:10.2471/BLT.11.090209
  11. Brooks-Pollock E, Tilston N, Edmunds WJ, Eames KT. Using an online survey of healthcare-seeking behaviour to estimate the magnitude and severity of the 2009 H1N1v influenza epidemic in England. BMC Infect Dis. 2011;11(1):68. doi:10.1186/1471-2334-11-68
  12. Khan SU, Anderson BD, Heil GL, Liang S, Gray GC. A systematic review and meta-analysis of the seroprevalence of influenza A (H9N2) infection among humans. J Infect Dis. 2015;212(4):562-9. doi:10.1093/infdis/jiv109
  13. Gerloff NA, Khan SU, Balish A, Shanta IS, Simpson N, Berman L, et al. Multiple reassortment events among highly pathogenic avian influenza A (H5N1) viruses detected in Bangladesh. Virology. 2014;450:297-307. doi:10.1016/j. virol.2013.12.023
  14. Hasan S, Ahmad SA, Masood R, Saeed S. Ebola virus: A global public health menace: A narrative review. J Family Med Prim Care. 2019;8(7):2189. doi:10.4103/jfmpc.jfmpc_ 297_19
  15. Hwang ES. Preparedness for prevention of Ebola virus disease. J Korean Med Sci. 2014;29(9):1185-. doi:10.3346/ jkms.2014.29.9.1185
  16. Espeland EM, Tsai CW, Larsen J, Disbrow GL. Safeguarding against Ebola: Vaccines and therapeutics to be stockpiled for future outbreaks. PLoS Negl Trop Dis. 2018;12(4):e0006275. doi:10.1371/journal.pntd.0006275
  17. Bishop BM. Potential and emerging treatment options for Ebola virus disease. Ann Pharmacother. 2015;49(2):196-206. doi:10.1177/1060028014561
  18. Nagarajan S, Tosh C, Smith DK, Peiris JS, Murugkar HV, Sridevi R, et al. Avian influenza (H5N1) virus of clade 2.3. 2 in domestic poultry in India. PLoS One. 2012;7(2):e31844. doi:10.1371/journal.pone.0031844
  19. Reid SM, Shell WM, Barboi G, Onita I, Turcitu M, Cioranu R, et al. First reported incursion of highly pathogenic notifiable avian influenza A H5N1 viruses from clade 2.3. 2 into European poultry. Transbound Emerg Dis. 2011;58(1):76-8. doi:10.1111/j.1865-1682.2010.01175.x
  20. Khan SU, Berman L, Haider N, Gerloff N, Rahman MZ, Shu B, et al. Investigating a crow die-off in January–February 2011 during the introduction of a new clade of highly pathogenic avian influenza virus H5N1 into Bangladesh. Arch Virol. 2014;159:509-18. doi:10.1007/s00705-013-1842-0
  21. Hu J, Zhao K, Liu X, Wang X, Chen Z, Liu X. Two highly pathogenic avian influenza H5N1 viruses of clade 2.3. 2.1 with similar genetic background but with different pathogenicity in mice and ducks. Transbound Emerg Dis. 2013;60(2):127-39. doi:10.1111/j.1865-1682.2012.01325.x
  22. Haider N, Sturm‐Ramirez K, Khan SU, Rahman MZ, Sarkar S, Poh MK, et al. Unusually high mortality in waterfowl caused by highly pathogenic avian influenza A (H5N1) in Bangladesh. Transbound Emerg Dis. 2017;64(1):144-56. doi:10.1111/tbed.12354
  23. Sarkar S, Khan SU, Mikolon A, Rahman MZ, Abedin J, Zeidner N, et al. An epidemiological study of avian influenza A (H5) virus in nomadic ducks and their raising practices in northeastern Bangladesh, 2011‐ Influenza Other Respir Viruses. 2017;11(3):275-82. doi:10.1111/irv.12438
  24. Loth L, Gilbert M, Osmani MG, Kalam AM, Xiao X. Risk factors and clusters of highly pathogenic avian influenza H5N1 outbreaks in Bangladesh. Prev Vet Med. 2010;96(1-2):104-13. doi:10.1016/j.prevetmed.2010.05.013
  25. Shanta IS, Hasnat MA, Zeidner N, Gurley ES, Azziz‐Baumgartner E, Sharker MA, et al. Raising backyard poultry in rural Bangladesh: financial and nutritional benefits, but persistent risky practices. Transbound Emerg Dis. 2017;64(5):1454-64. doi:10.1111/tbed.12536
  26. Nasreen S, Khan SU, Luby SP, Gurley ES, Abedin J, Zaman RU, et al. Highly pathogenic avian influenza A (H5N1) virus infection among workers at live bird markets, Bangladesh, 2009–2010. Transbound Emerg Dis. 2015;21(4):629. doi:10.3201/eid2104.141281
  27. Biswas PK, Giasuddin M, Nath BK, Islam MZ, Debnath NC, Yamage M. Biosecurity and circulation of influenza A (H5N1) virus in live‐bird markets in Bangladesh, 2012. Transbound Emerg Dis. 2017;64(3):883-91. doi:10.1111/ tbed.12454
  28. Ansari WK, Parvej MS, El Zowalaty ME, Jackson S, Bustin SA, Ibrahim AK, et al. Surveillance, epidemiological, and virological detection of highly pathogenic H5N1 avian influenza viruses in duck and poultry from Bangladesh. Vet 2016;193:49-59. doi:10.1016/j.vetmic.2016.07.025
  29. Negovetich NJ, Feeroz MM, Jones-Engel L, Walker D, Alam SR, Hasan K, et al. Live bird markets of Bangladesh: H9N2 viruses and the near absence of highly pathogenic H5N1 influenza. PloS One. 2011;6(4):e19311. doi:10.1371/journal. pone.0019311
  30. Gerloff NA, Khan SU, Zanders N, Balish A, Haider N, Islam A, et al. Genetically diverse low pathogenicity avian influenza A virus subtypes co-circulate among poultry in Bangladesh. PloS One. 2016;11(3):e0152131. doi:10.1371/ journal.pone.0152131
  31. Abdelwhab EM, Selim AA, Arafa A, Galal S, Kilany WH, Hassan MK, et al. Circulation of avian influenza H5N1 in live bird markets in Egypt. Avian Dis. 2010;54(2):911-4. doi:10.1637/9099-100809-RESNOTE.1
  32. Lockhart C, Wuryaninggsih E, Brum E, Barrios PR. Prevalence of HPAI in live-bird markets in the Jabodatabek region of west Java, Indonesia in 2009. Int J Infect Dis. 2010;14:e167. doi:10.1016/j.ijid.2010.02.1852
  33. Pepin KM, Wang J, Webb CT, Smith GJ, Poss M, Hudson PJ, et al. Multiannual patterns of influenza A transmission in Chinese live bird market systems. Influenza Other Respir Viruses. 2013;7(1):97-107. doi:10.1111/j.1750-2659.2012. 00354.x
  34. Sun W, Li J, Hu J, Jiang D, Xing C, Zhan T, Liu X. Genetic analysis and biological characteristics of different internal gene origin H5N6 reassortment avian influenza virus in China in 2016. Vet Microbiol. 2018;219:200-11. doi:10.1016/j.vetmic.2018.04.023
  35. Tada T, Suzuki K, Sakurai Y, Kubo M, Okada H, Itoh T, et al. NP body domain and PB2 contribute to increased virulence of H5N1 highly pathogenic avian influenza viruses in chickens. J Virol. 2011;85(4):1834-46. doi:10.1128/jvi. 01648-10
  36. Nguyen LT, Schmidt HA, Von Haeseler A, Minh BQ. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol. 2015;32(1): 268-74. doi:10.1093/molbev/msu300
  37. Wu J, Ke C, Lau EH, Song Y, Cheng KL, Zou L, et al. Influenza H5/H7 virus vaccination in poultry and reduction of zoonotic infections, Guangdong Province, China, 2017–18. Emerg Infect Dis. 2019;25(1):116. doi:10.3201/ eid2501.181259
  38. Bi Y, Tan S, Yang Y, Wong G, Zhao M, Zhang Q, et al. Clinical and immunological characteristics of human infections with H5N6 avian influenza virus. Clin Infect Dis. 2019;68(7):1100-9. doi:10.1093/cid/ciy681
  39. Yang ZF, Mok CK, Peiris JS, Zhong NS. Human infection with a novel avian influenza A (H5N6) virus. N Engl J Med. 2015;373(5):487-9. doi:10.1056/NEJMc1502983
  40. Bi Y, Chen Q, Wang Q, Chen J, Jin T, Wong G, et al. Genesis, evolution and prevalence of H5N6 avian influenza viruses in China. Cell Host Microbe. 2016;20(6):810-21. doi:10.1016/j.chom.2016.10.022
  41. Poen MJ, Venkatesh D, Bestebroer TM, Vuong O, Scheuer RD, Oude Munnink BB, et al. Co-circulation of genetically distinct highly pathogenic avian influenza A clade 2.3. 4.4 (H5N6) viruses in wild waterfowl and poultry in Europe and East Asia, 2017–18. Virus Evol. 2019;5(1):vez004. doi:10.1093/ve/vez004
  42. Su S, Gu M, Liu D, Cui J, Gao GF, Zhou J, et al. Epidemiology, evolution, and pathogenesis of H7N9 influenza viruses in five epidemic waves since 2013 in China. Trends Microbiol. 2017;25(9):713-28. doi:10.1016/ j.tim.2017.06.008
  43. Sutton TC. The pandemic threat of emerging H5 and H7 avian influenza viruses. Viruses. 2018;10(9):461. doi:10.33 90/v10090461
  44. Worobey M, Han GZ, Rambaut A. A synchronized global sweep of the internal genes of modern avian influenza virus. Nature. 2014;508(7495):254-7. doi:10.1038/nature13016
  45. Oxford JS, Gill D. Unanswered questions about the 1918 influenza pandemic: origin, pathology, and the virus itself. Lancet Infect Dis. 2018;18(11):e348-54. doi:1016/S1473-3099(18)30359-1
  46. Tong S, Li Y, Rivailler P, Conrardy C, Castillo DA, Chen LM, Recuenco S, Ellison JA, Davis CT, York IA, Turmelle AS. A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci USA. 2012;109(11):4269-74. doi:10.1073/pnas.1 116200109
  47. Paules CI, McDermott AB, Fauci AS. Immunity to influenza: catching a moving target to improve vaccine design. J Immunol. 2019;202(2):327-31. doi:10.4049/jimmunol. 1890025
  48. Rozo M, Gronvall GK. The reemergent 1977 H1N1 strain and the gain-of-function debate. MBio. 2015;6(4):10-128. doi:10.1128/mbio.01013-15
  49. Belser JA, Katz JM, Tumpey TM. The ferret as a model organism to study influenza A virus infection. Dis Model Mech. 2011;4(5):575-9. doi:10.1242/dmm.007823
  50. Lowen AC, Bouvier NM, Steel J. Transmission in the guinea pig model. Influenza Pathogenesis and Control-Volume I. 2014:157-83. doi:10.1007/82_2014_390
  51. Belser JA, Eckert AM, Tumpey TM, Maines TR. Complexities in ferret influenza virus pathogenesis and transmission models. Microbiol Mol Biol Rev. 2016;80(3):733-44. doi:10.1128/mmbr.00022-16
  52. Xu Q, Wang W, Cheng X, Zengel J, Jin H. Influenza H1N1 A/Solomon Island/3/06 virus receptor binding specificity correlates with virus pathogenicity, antigenicity, and immunogenicity in ferrets. J Virol. 2010;84(10):4936-45. doi:10.1128/jvi.02489-09
  53. de Graaf M, Fouchier RA. Role of receptor binding specificity in influenza A virus transmission and pathogenesis. EMBO J. 2014;33(8):823-41. doi:10.1002/ embj.201387442
  54. Pappas C, Yang H, Carney PJ, Pearce MB, Katz JM, Stevens J, et al. Assessment of transmission, pathogenesis and adaptation of H2 subtype influenza viruses in ferrets. Virology. 2015;477:61-71. doi:10.1016/j.virol.2015.01.002
  55. Spekreijse D, Bouma A, Koch G, Stegeman JA. Airborne transmission of a highly pathogenic avian influenza virus strain H5N1 between groups of chickens quantified in an experimental setting. Vet Microbiol. 2011;152(1-2):88-95. doi:1016/j.vetmic.2011.04.024
  56. Buhnerkempe MG, Gostic K, Park M, Ahsan P, Belser JA, Lloyd-Smith JO. Mapping influenza transmission in the ferret model to transmission in humans. Elife. 2015;4:e07969.
  57. Nishiura H, Yen HL, Cowling BJ. Sample size considerations for one-to-one animal transmission studies of the influenza A viruses. PloS One. 2013;8(1):e55358. doi:10.1371/ journal.pone.0055358
  58. Richard M, Fouchier RA. Influenza A virus transmission via respiratory aerosols or droplets as it relates to pandemic potential. FEMS Microbiol Rev. 2016;40(1):68-85. doi:10.1 093/femsre/fuv039
  59. Pappas C, Viswanathan K, Chandrasekaran A, Raman R, Katz JM, Sasisekharan R, et al. Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957. PloS One. 2010;5(6):e11158. doi:10.1 371/journal.pone.0011158
  60. Roberts KL, Shelton H, Scull M, Pickles R, Barclay WS. Lack of transmission of a human influenza virus with avian receptor specificity between ferrets is not due to decreased virus shedding but rather a lower infectivity in vivo. J Gen Virol. 2011;92(8):1822-31. doi:10.1099/vir.0.031 203-0
  61. Costello DA, Whittaker GR, Daniel S. Variations in pH sensitivity, acid stability, and fusogenicity of three influenza virus H3 subtypes. J Virol. 2015;89(1):350-60. doi:10.11 28/jvi.01927-14
  62. Galloway SE, Reed ML, Russell CJ, Steinhauer DA. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog. 2013;9(2):e1003151. doi:10.1371/ journal.ppat.1003151
  63. SJCEIRS H9 Working Group. Assessing the fitness of distinct clades of influenza A (H9N2) viruses. Emerg. microbes & infect. 2013;2(11):e75. doi:10.1038/emi.2013.75
  64. Zaraket H, Baranovich T, Kaplan BS, Carter R, Song MS, Paulson JC, et al. Mammalian adaptation of influenza A (H7N9) virus is limited by a narrow genetic bottleneck. Nat Commun. 2015;6(1):6553. doi:10.1038/ncomms7553
  65. Zaraket H, Bridges OA, Duan S, Baranovich T, Yoon SW, Reed ML, Salomon R, Webby RJ, Webster RG, Russell CJ. Increased acid stability of the hemagglutinin protein enhances H5N1 influenza virus growth in the upper respiratory tract but is insufficient for transmission in ferrets. J Virol. 2013;87(17):9911-22. doi:10.1128/jvi.01175-13
  66. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, De Wit E, Munster VJ, et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science. 2012;336(6088):1534-41. doi:10.1126/science.1213362
  67. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature. 2012;486(7403):420-8. doi:10.1038/nature10831
  68. Lakdawala SS, Lamirande EW, Suguitan Jr AL, Wang W, Santos CP, Vogel L, et al. Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus. PLoS Pathog. 2011;7(12):e1002443. doi:10.1371/journal. ppat.1002443
  69. Yen HL, Liang CH, Wu CY, Forrest HL, Ferguson A, Choy KT, et al. Hemagglutinin–neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1 influenza virus in ferrets. Proc Natl Acad Sci USA. 2011;108(34):14264-9. doi:10.1073/pnas.1111000108
  70. Zanin M, Marathe B, Wong SS, Yoon SW, Collin E, Oshansky C, et al. Pandemic swine H1N1 influenza viruses with almost undetectable neuraminidase activity are not transmitted via aerosols in ferrets and are inhibited by human mucus but not swine mucus. J Virol. 2015;89(11):5935-48. doi:1128/jvi.02537-14
  71. Campbell PJ, Kyriakis CS, Marshall N, Suppiah S, Seladi-Schulman J, Danzy S, et al. Residue 41 of the Eurasian avian-like swine influenza a virus matrix protein modulates virion filament length and efficiency of contact transmission. J Virol. 2014;88(13):7569-77. doi:10.1128/jvi.00119-14
  72. Gao HN, Lu HZ, Cao B, Du B, Shang H, Gan JH, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med. 2013;368(24):2277-85. doi:10.1 056/NEJMoa1305584
  73. To KK, Ng KH, Que TL, Chan JM, Tsang KY, Tsang AK, et al. Avian influenza A H5N1 virus: a continuous threat to humans. Emerg. microbes & infect. 2012;1(1):1-2. doi:10.10 38/emi.2012.24
  74. Suguitan Jr AL, Matsuoka Y, Lau YF, Santos CP, Vogel L, Cheng LI, et al. The multibasic cleavage site of the hemagglutinin of highly pathogenic A/Vietnam/1203/2004 (H5N1) avian influenza virus acts as a virulence factor in a host-specific manner in mammals. J Virol. 2012;86(5):2706-14. doi:10.1128/jvi.05546-11
  75. Belser JA, Tumpey TM. Mammalian models for the study of H7 virus pathogenesis and transmission. Influenza Pathogenesis and Control-Volume I. 2014:275-305. doi:10.1007/82_2014_383
  76. Smith GJ, Donis RO, World Health Organization/World Organisation for Animal Health/Food and Agriculture Organization (WHO/OIE/FAO) H5 Evolution Working Group. Nomenclature updates resulting from the evolution of avian influenza A (H5) virus clades 2.1. 3.2 a, 2.2. 1, and 2.3. 4 during 2013–2014. Influenza Other Respir Viruses. 2015;9(5):271-6. doi:10.1111/irv.12324
  77. Kok WL, Denney L, Benam K, Cole S, Clelland C, McMichael AJ, et al. Pivotal Advance: Invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection. J Leukoc Biol. 2012;91(3):357-68. doi:10.1189/jlb.0411184
  78. Liu WB, Li ZX, Du Y, Cao GW. Ebola virus disease: from epidemiology to prophylaxis. Mil Med Res. 2015;2(1):7. doi:10.1186/s40779-015-0035-4
  79. Schindell BG, Webb AL, Kindrachuk J. Persistence and sexual transmission of filoviruses. Viruses. 2018;10(12):683. doi:10.3390/v10120683
  80. Gebretadik FA, Seifu MF, Gelaw BK. Review on Ebola virus disease: its outbreak and current status. Epidemiology. 2015;5:1-8. doi:10.4172/2161-1165.1000204
  81. Vailaya C, Kumar S, Moideen S. Ebola virus disease: practices health care professionals in a Tertiary Care Hospital. J Pub Health Med Res. 2014;2(2):13-8.
  82. Galvin S, Flint SR, Healy CM. Ebola virus disease: review and implications for dentistry in Ireland. 2015.
  83. Samaranayake L, Scully C, Nair RG, Petti S. Viral haemorrhagic fevers with emphasis on Ebola virus disease and oro‐dental healthcare. Oral Dis. 2015;21(1):1-6. doi:10.1111/odi.12298
  84. Zhou G, Juang SW, Kane KP. NK cells exacerbate the pathology of influenza virus infection in mice. Eur J Immunol. 2013;43(4):929-38. doi:10.1002/eji.201242620
Hospital Practices and Research
Volume 8, Issue 2 - Serial Number 30
Spring 2023
Pages 270-279

Home

Guide for Authors

Submit Manuscript

Reviewers

Contact Us